APA (7th ed.) Citation

Eriksson, B., & Feuring, M. (2016). An open-label study of the pharmacokinetics and pharmacodynamics of dabigatran etexilate 150mg once daily in Caucasian patients with moderate renal impairment undergoing primary unilateral elective total knee or hip replacement surgery. Thrombosis research, 144, . https://doi.org/10.1016/j.thromres.2016.06.017

Chicago Style (17th ed.) Citation

Eriksson, Bengt, and Martin Feuring. "An Open-label Study of the Pharmacokinetics and Pharmacodynamics of Dabigatran Etexilate 150mg Once Daily in Caucasian Patients with Moderate Renal Impairment Undergoing Primary Unilateral Elective Total Knee or Hip Replacement Surgery." Thrombosis Research 144 (2016). https://doi.org/10.1016/j.thromres.2016.06.017.

MLA (9th ed.) Citation

Eriksson, Bengt, and Martin Feuring. "An Open-label Study of the Pharmacokinetics and Pharmacodynamics of Dabigatran Etexilate 150mg Once Daily in Caucasian Patients with Moderate Renal Impairment Undergoing Primary Unilateral Elective Total Knee or Hip Replacement Surgery." Thrombosis Research, vol. 144, 2016, https://doi.org/10.1016/j.thromres.2016.06.017.